PRME - FDA clears Prime Medicine to begin gene therapy clinical testing April, 29 2024 04:11 PM First Trust Heitman Global Prime Real Estate ETF 2024-04-29 16:11:48 ET More on Prime Medicine Prime Medicine down 5%, prices $140M stock offering Prime Medicine stock falls on proposed public offering of common stock Seeking Alpha’s Quant Rating on Prime Medicine Historical earnings data for Prime Medicine Financial information for Prime Medicine For further details see: FDA clears Prime Medicine to begin gene therapy clinical testing